Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Niacin on Fatty Acid Trafficking in Obesity and Type 2 Diabetes
NCT03867500Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Nov 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of niacin in type 2 diabetes mellitus (T2DM) and obesity, sponsored by Mayo Clinic. Primary endpoint: Glucose Infusion Rate at 18 hours. Started Nov 2018; status: completed.
02
Drugs
niacin
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT03867500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03867500.